Topic
Private Credit Research
Within the private credit landscape, researchers emphasize the continued importance of private markets and direct lending as essential tools for diversifying portfolios amidst heightened geopolitical uncertainty and credit stress. While direct lending remains supported, analysts advocate for strict selectivity with a bias toward non-cyclical sectors and infrastructure for inflation-linked income. Credit strategies demonstrated resilience with positive returns in early 2026, though a more defensive posture is emerging through the prioritization of Relative Value and Fixed Income Relative Value sub-strategies. Solid corporate fundamentals and projected S&P 500 EPS growth of 20% support the credit outlook, even as high government deficits pose long-term risks to yields and necessitate a focus on shorter-duration fixed income. Additionally, the massive expansion in AI-related demand, with a projected $1.7 trillion TAM by 2030, and the evolution of biotech into a compounding asset class are creating new long-term investment opportunities for credit providers. Collectively, these insights suggest a research direction focused on resilient, innovation-driven sectors to navigate a goldilocks environment disrupted by macro volatility.
4559 reports available
All reports
Page 133 of 160
Inflation Concerns Lift the Dollar and Market Rates
SEB · May 14, 2026
Navigate26 Showcases Potential for Multi-Year Market Share Gains
Goldman Sachs · May 14, 2026
Equity Client Flow Trends Big Tech Inflows During Sector Rally
Bank of America · May 14, 2026
Sysmex Earnings Review Results In Line
Goldman Sachs · May 14, 2026
Versant Media Group 1Q26 First Take
Goldman Sachs · May 14, 2026
Schroders Credit Lens GBP Investor Perspective
Schroders · May 14, 2026
Emerging Market Debt Resilience in a More Volatile World
Carmignac · May 14, 2026
Anritsu CFO Call Takeaways: Numerous Drivers to Improve Margins in Optical Test Equipment
Goldman Sachs · May 14, 2026
National Grid FY 2026 Results
Goldman Sachs · May 14, 2026
Pause for Breath, Siemens Upgrades
J.P. Morgan · May 14, 2026
First Take: Alibaba Health 2H FY26 Results
Goldman Sachs · May 14, 2026
Merck KGaA Process Solutions De-risked for 2026
Goldman Sachs · May 14, 2026
Lotes: Material Cost Remains a Near-Term Overhang
Goldman Sachs · May 14, 2026
Dividend Payments to Ease CNY Appreciation Pressure
Bank of America · May 14, 2026
Americas Healthcare Biotechnology 1Q26 EPS Updates
Goldman Sachs · May 14, 2026
Andina Model Update Post Q1
Goldman Sachs · May 14, 2026
Air New Zealand Market Update on FY26 Outlook
Goldman Sachs · May 14, 2026
Inside Commodities
LSEG Data & Analytics · May 14, 2026
Tau Data Calls for Further Analysis into Ph3 Start
Goldman Sachs · May 14, 2026
Australian Morning Focus
ANZ · May 14, 2026
Americas Retail Sales April Update
Goldman Sachs · May 14, 2026
Allogene Therapeutics Look to First Autoimmune CAR T Data in 4Q
Goldman Sachs · May 14, 2026
ADES Expanded Global Offshore Platform Yields Diversification Benefits
Goldman Sachs · May 14, 2026
Allegro 1Q26 Results and FY26 Outlook Upgrade
Goldman Sachs · May 14, 2026